These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34065416)

  • 1. Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K
    Yamakawa H; Setoguchi S; Goto S; Watase D; Terada K; Nagata-Akaho N; Toki E; Koga M; Matsunaga K; Karube Y; Takata J
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs for Skin Delivery of Menahydroquinone-4, an Active Form of Vitamin K
    Goto S; Setoguchi S; Yamakawa H; Watase D; Terada K; Matsunaga K; Karube Y; Takata J
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor effects of novel intracellular delivery of an active form of menaquinone-4, menahydroquinone-4, into hepatocellular carcinoma.
    Setoguchi S; Watase D; Matsunaga K; Matsubara M; Kubo Y; Kusuda M; Nagata-Akaho N; Enjoji M; Nakashima M; Takeshita M; Karube Y; Takata J
    Cancer Prev Res (Phila); 2015 Feb; 8(2):129-38. PubMed ID: 25416411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Effects and Delivery Profiles of Menahydroquinone-4 Prodrugs with Ionic or Nonionic Promoiety to Hepatocellular Carcinoma Cells.
    Setoguchi S; Watase D; Matsunaga K; Yamakawa H; Goto S; Terada K; Ohe K; Enjoji M; Karube Y; Takata J
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30013007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery.
    Takata J; Karube Y; Hanada M; Matsunaga K; Matsushima Y; Sendo T; Oishi R
    Pharm Res; 1995 Dec; 12(12):1973-9. PubMed ID: 8786976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of the reduced form of vitamin K
    Toki E; Goto S; Setoguchi S; Terada K; Watase D; Yamakawa H; Yamada A; Koga M; Kubota K; Iwasaki K; Karube Y; Matsunaga K; Takata J
    Sci Rep; 2022 Nov; 12(1):19878. PubMed ID: 36400879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.
    Enjoji M; Watase D; Matsunaga K; Kusuda M; Nagata-Akaho N; Karube Y; Takata J
    Diseases; 2015 Jul; 3(3):150-158. PubMed ID: 28943616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug resistance of acute promyelocytic leukemia (APL) to all-trans retinoic acid (ATRA) and its reversion].
    Jiang G; Tang T; Bi K
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):154-7. PubMed ID: 11776647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: human liver enzymatic activation and its action in warfarin-poisoned human liver.
    Takata J; Karube Y; Hanada M; Matsunaga K; Iwasaki H
    Biol Pharm Bull; 1999 Feb; 22(2):172-8. PubMed ID: 10077437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
    Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
    Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
    Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
    Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6.
    Li S; Jin X; Wu H; Wang Y; Li X; Guo Y; Liang S
    PLoS One; 2017; 12(6):e0180142. PubMed ID: 28665981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis.
    Manikam SD; Stanslas J
    J Pharm Pharmacol; 2009 Jan; 61(1):69-78. PubMed ID: 19126299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
    Makishima M; Umesono K; Shudo K; Naoe T; Kishi K; Honma Y
    Blood; 1998 Jun; 91(12):4715-26. PubMed ID: 9616170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias.
    Barber N; Belov L; Christopherson RI
    Leuk Res; 2008 Feb; 32(2):315-22. PubMed ID: 17561254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species-regulated glycogen synthase kinase-3β activation contributes to all-trans retinoic acid-induced apoptosis in granulocyte-differentiated HL60 cells.
    Wang CY; Yang TT; Chen CL; Lin WC; Lin CF
    Biochem Pharmacol; 2014 Mar; 88(1):86-94. PubMed ID: 24406248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.